Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.

Source:http://linkedlifedata.com/resource/pubmed/id/10561351

Download in:

View as

General Info

PMID
10561351